PRSO insider option grant — 25,000 shares, 10‑year term
Rhea-AI Filing Summary
Brad Lynch, identified in the filing as the Chief Operating Officer of Peraso, Inc. (PRSO), reported receipt of a stock option grant on 08/07/2025. The award comprises 25,000 options to purchase common stock at an exercise price of $0.8399, with a stated expiration of 08/07/2035.
The option vests monthly at 1/36th of the shares following the grant date, the acquisition is reported as an “A” (acquired) transaction, and the filing shows 25,000 derivative securities beneficially owned following the transaction, held in a direct ownership form. The Form 4 was filed by one reporting person and includes explanatory notes on vesting and reporting conventions.
Positive
- 25,000 option grant disclosed with explicit terms
- Exercise price $0.8399 and expiration 08/07/2035 clearly stated
- Vesting schedule (1/36th monthly) is documented in the filing
Negative
- None.
Insights
TL;DR: Standard executive option grant—25,000 options, 10-year term, monthly vesting; likely intended to link pay to long-term performance.
The grant of 25,000 stock options at a $0.8399 exercise price with a 10‑year expiration is consistent with common long-term incentive structures for senior executives. The 1/36th monthly vesting indicates multi-year retention goals. Reported as a direct acquisition on 08/07/2025, the award is documented with explanatory notes clarifying vesting schedules and reporting conventions. From a compensation design perspective, this is routine and aligns future payout to share performance over an extended horizon.
TL;DR: Routine Form 4 disclosure of an insider option grant; materiality to shareholders appears limited from the disclosed size.
The filing transparently reports an option grant to COO Brad Lynch: 25,000 underlying shares, exercise price $0.8399, vesting at 1/36th monthly and expiring 08/07/2035. The Form 4 was filed by a single reporting person and lists the ownership form as direct. This disclosure fulfills Section 16 reporting requirements and provides clear vesting and term details. Based solely on the disclosed quantities and terms, the item appears to be a routine compensation award rather than a governance red flag.